Advertisement
Canada markets open in 57 minutes
  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CAD/USD

    0.7299
    +0.0001 (+0.01%)
     
  • CRUDE OIL

    83.27
    +0.46 (+0.56%)
     
  • Bitcoin CAD

    87,841.55
    -3,419.70 (-3.75%)
     
  • CMC Crypto 200

    1,362.96
    -19.61 (-1.42%)
     
  • GOLD FUTURES

    2,338.90
    +0.50 (+0.02%)
     
  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     
  • 10-Yr Bond

    4.6520
    0.0000 (0.00%)
     
  • NASDAQ futures

    17,466.25
    -198.25 (-1.12%)
     
  • VOLATILITY

    16.38
    +0.41 (+2.57%)
     
  • FTSE

    8,102.80
    +62.42 (+0.78%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • CAD/EUR

    0.6816
    -0.0003 (-0.04%)
     

3 COVID Stocks That Might Double Soon

3 COVID Stocks That Might Double Soon

Read more to find out why we think Novavax (NASDAQ: NVAX), Sorrento Therapeutics (NASDAQ: SRNE), and InMode (NASDAQ: INMD) will close out 2021 with a bang. Taylor Carmichael (Novavax): Novavax stock has already doubled this year, running from $112 back in January to $233 this week. Right now, Moderna enjoys a $169 billion market cap, and BioNTech sports a $79 billion valuation.